Australian Medical Research Advisory Board

Page last updated: 20 December 2017

The Government established the independent Australian Medical Research Advisory Board as per the requirements of the Medical Research Future Fund Act 2015 in April 2016. The Advisory Board comprises leading experts in medical research and innovation, and health policy and commercialisation, including experience and knowledge in philanthropy, consumer issues and translating research into frontline healthcare. The Advisory Board is tasked with determining the Australian Medical Research and Innovation Strategy and related Priorities to inform Government decision making on Medical Research Future Fund disbursements.

Members of the Advisory Board

  • Chair: Professor Ian Frazer AC is a scientist and previous Chief Executive Officer (CEO) and Director of Research of the Translational Research Institute. He is now Chair of the Translation Research Institute Foundation Board. Professor Frazer is President of the Australian Academy of Health and Medical Science and member of the Commonwealth Science Council. He is also Chairman of the Australian Cancer Research Foundation's Medical Research Advisory Committee.
  • Member: Mr Yasser El-Ansary is the Chief Executive of the Australian Private Equity and Venture Capital Association where he is responsible for leading the strategic direction of the organisation’s work in representing the private equity and venture capital industry in Australia.
  • Member: Professor Douglas Hilton AO is Director of the Walter and Eliza Hall Institute, Head of the Department of Medical Biology at The University of Melbourne and former president of the Association of Australian Medical Research Institute.
  • Member: Professor Peter Høj is Vice Chancellor and President of the University of Queensland, and chair of the Group of Eight board. Before this, he was Vice-Chancellor and President of the University of South Australia; and CEO of the Australian Research Council.
  • Member: Dr Deborah Rathjen is CEO and Managing Director of the Bionomics Corporation.
  • Member: Professor Karen Reynolds is Director of the Medical Device Research Institute and the Medical Device Partnering Program, as well as Dean (Research) of the College of Science and Engineering at Flinders University.
  • Member: Ms Jennifer Williams AM is the former Chief Executive of the Australian Red Cross Blood Service and is currently the Northern Health (Victoria) Board Chair.
  • Ex-Officio Member: Professor Anne Kelso AO is the CEO of the National Health and Medical Research Council.

These individuals are highly regarded public figures both within the health and medical research sector and the wider Australian community. They have been selected to ensure that the Advisory Board has the right skills and experience to deliver on the objectives of the MRFF.

Australia has such a strong track record in medical research and discoveries, and the members of the Advisory Board have all played a part in building this foundation.

Australian Medical Research Advisory Board Communiqué – Funding Principles

Word version: Communiqué from the Australian Medical Research Advisory Board - Funding Principles - 6 December 2017 (Word 4218 KB)
PDF version: Communiqué from the Australian Medical Research Advisory Board - Funding Principles - 6 December 2017 (PDF 302 KB)

Australian Medical Research Advisory Board Communiqué – Meeting 1

Word version: Communiqué from the Australian Medical Research Advisory Board 4 May 2016 meeting - Word 31 KB
PDF version: Communiqué from the Australian Medical Research Advisory Board 4 May 2016 meeting - PDF 89 KB

In this section